XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of additional shares approved for grant (in shares) 100,000    
Total compensation cost not yet recognized $ 3,200    
Total compensation cost not yet recognized, period for recognition 2 years 6 months    
Information regarding options exercised [Abstract]      
Intrinsic value $ 279 $ 117  
Cash proceeds received 66 32  
Tax benefit realized 98 41  
Long-term Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense recognized 400 400  
Tax benefit relating to compensation expense recognized $ 100 $ 100  
Stock Options [Member]      
Number of Shares [Roll Forward]      
Outstanding, beginning balance (in shares) 211,018    
Granted (in shares) 0    
Exercised (in shares) (15,992)    
Forfeited (in shares) 0    
Expired (in shares) 0    
Outstanding, ending balance (in shares) 195,026    
Vested and expected to vest, period end (in shares) 195,026    
Exercisable, period end (in shares) 195,026    
Average Exercise Price [Roll Forward]      
Outstanding, beginning balance (in dollars per share) $ 5.05    
Exercised (in dollars per share) 4.14    
Outstanding, ending balance (in dollars per share) 5.12    
Vested and expected to vest, period end (in dollars per share) 5.12    
Exercisable, period end (in dollars per share) $ 5.12    
Weighted-Average Remaining Contractual Term (Years) [Abstract]      
Outstanding, Weighted Average Remaining Contractual Term 4 years 10 months 6 days    
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term 4 years 10 months 6 days    
Exercisable, Weighted Average Remaining Contractual Term 4 years 10 months 6 days    
Aggregate Intrinsic Value [Abstract]      
Outstanding, Aggregate Intrinsic Value $ 3,038    
Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 3,038    
Exercisable, Aggregate Intrinsic Value $ 3,038    
Non Vested Restricted Stock and PSU's [Member]      
Number of Shares [Roll Forward]      
Outstanding, beginning balance (in shares) 296,422    
Granted (in shares) 68,473    
Vested (in shares) (50,297)    
Forfeited (in shares) (5,727)    
Outstanding, ending balance (in shares) 308,871    
Weighted Average Grant Date Fair Value [Roll Forward]      
Outstanding, beginning balance (in dollars per share) $ 14.52    
Granted (in dollars per share) 21.07    
Vested (in dollars per share) 14.81    
Forfeited (in dollars per share) 15.57    
Outstanding, ending balance (in dollars per share) $ 15.85    
Directors [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares issues as retainer fees (in shares) 2,000 2,000  
Non-Employee Directors [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of additional shares approved for grant (in shares) 200,000    
Total compensation expense recognized $ 40 $ 30  
Tax benefit relating to compensation expense recognized $ 10 $ 10  
Officers [Member] | Restricted Stock [Member] | Long-term Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of stock units or restricted shares issued in period (in shares) 50,000 70,000  
Vesting period 3 years 3 years  
Officers [Member] | Performance Stock Units [Member] | Long-term Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of stock units or restricted shares issued in period (in shares) 20,000 30,000  
Vesting period   3 years 3 years